| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-382
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 |
| filingDate |
2019-01-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab915b585ff8b038515c0a6a566b4c1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e30ea2ca2890dfc60e02acda1797f57e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_935eab7e57ac534a7bedd63938fcb75e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2343fc4e67a86de8529f50aa38398829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a77a51567eb3c02b665bc1fa7312479c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51927b2e8690b0486896191f39636462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5994a7cd89982d289de66b3cd4a3068d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2aa321d89c98fd40797f8caf56741ceb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae9e2dd7a00dc6bfbc30c7eba8427d2c |
| publicationDate |
2020-11-25^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3741754-A1 |
| titleOfInvention |
Crystal form of indole derivative and preparation method and use thereof |
| abstract |
Disclosed are a crystal form of an indole derivative (compound 1) and a pharmaceutical composition and preparation method thereof. The crystal form is used to prepare a drug for treating a disease related to a CRTH2 receptor. |
| priorityDate |
2018-01-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |